查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576799

消化道出血治疗设备市场：按产品类型、治疗类型和最终用户划分 - 全球预测 2025-2030

Gastrointestinal Bleeding Treatment Devices Market by Product Type (Endoscopic Hemostatic Devices, Radiological Interventions), Treatment Type (Drug Therapy, Endoscopic Treatment, Surgical Treatment), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年消化道出血治疗器材市值为5.3443亿美元，预计2024年将达5.5943亿美元，复合年增长率为5.26%，到2030年将达到7.6543亿美元。

消化道出血治疗设备市场由各种旨在诊断、管理和治疗胃肠道出血的医疗技术定义。这个市场的需求根源在于溃疡、静脉曲张和癌症等胃肠道疾病的流行，这些疾病会导致严重的出血事件，因此需要高效且有效的介入设备。这些设备的应用范围从内视镜介入、开放性手术和微创手术到医院、专科诊所和门诊手术中心。主要最终用途领域包括胃肠外科、急诊科和专科门诊。目前该市场受到胃肠道疾病发病率增加、全球人口老化以及微创手术技术进步等因素的推动。先进成像技术和人工智慧诊断的整合也处于行业成长的前沿，为企业利用技术联盟和跨行业合作创造了机会。然而，市场面临严格的监管要求、先进设备的高成本以及对熟练医疗保健专业人员的需求等挑战。新兴市场有限的医疗基础设施也可能阻碍市场成长。该领域的创新者应专注于开发具有成本效益的携带式解决方案，并透过人工智慧和机器学习提高设备精度。具有巨大潜力的研究领域包括开发用于临时干预的生物分解性材料和用于即时出血检测的感测器技术。公司应考虑采取强有力的研发倡议来满足特定需求，例如不同临床环境中的多功能性以及针对不同胃肠道疾病的设备分层的便利性。为了发现开拓的商机，必须了解区域市场的微妙动态，特别是卫生系统正在扩张的亚太和拉丁美洲。最终，透过培育与医疗保健提供者的伙伴关係并不断响应监管变化，我们可以显着加强我们在这个不断发展的市场中的地位。

主要市场统计
基准年[2023] 53443万美元
预测年份 [2024] 55943万美元
预测年份 [2030] 76543万美元
复合年增长率（%） 5.26%

市场动态：快速发展的消化道出血治疗设备市场的关键市场洞察

消化道出血治疗设备市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 政府对消化道出血治疗的倡议和优惠报销政策
    • 增加新兴国家的医疗保健支出并改善医疗基础设施
    • 越来越多地采用微创技术来治疗消化道出血
    • 主要企业之间的联盟与合作，促进产品开发与市场开拓
  • 市场限制因素
    • 先进消化道出血治疗技术的开发与部署高成本
    • 一般医疗保健提供者对消化道出血治疗进展的认识有限
  • 市场机会
    • 将先进的诊断成像技术整合到消化道出血治疗设备中，以实现早期发现并提高准确性
    • 透过消化道出血治疗设备製造商和医疗保健提供者之间的合作改善患者照护和治疗结果
  • 市场挑战
    • 复杂的患者需求需要开发高度专业的消化道出血治疗解决方案

波特五力：驾驭消化道出血治疗设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解消化道出血治疗设备市场的外部影响

外部宏观环境因素在塑造消化道出血治疗设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解消化道出血治疗器材市场竞争状况

对消化道出血治疗设备市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵消化道出血治疗设备市场供应商的绩效评估

FPNV 定位矩阵是评估消化道出血治疗设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘消化道出血治疗设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对消化道出血治疗设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 政府对消化道出血治疗的倡议和优惠报销政策
      • 新兴国家的医疗保健成本增加并改善医疗保健基础设施
      • 越来越多采用微创手术治疗消化道出血
      • 主要参与者之间的合作和伙伴关係，以推动产品开发和市场成长
    • 抑制因素
      • 开发引进先进消化道出血治疗技术高成本
      • 一般医疗保健专业人员对消化道出血治疗进展的认识有限
    • 机会
      • 将先进的诊断影像技术融入消化道出血治疗设备中，以实现早期发现并提高准确性
      • 消化道出血治疗设备製造商和医疗保健提供者之间的合作，以改善患者照护和结果
    • 任务
      • 复杂的患者需求需要开发高度专业的消化道出血治疗解决方案。
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章消化道出血治疗设备市场：依产品类型

  • 内视镜止血装置
    • 止血夹
    • 注射装置
    • 喷涂设备
    • 热装置
  • 放射治疗
    • 栓塞剂
    • 硬化剂

第七章依治疗类型分類的消化道出血治疗设备市场

  • 药物治疗
    • Octreotide
    • 特利加压素
  • 内视镜治疗
    • 注射疗法
    • 机械处理
    • 热凝固
  • 手术治疗
    • 腹腔镜手术
    • 开放性手术

第八章消化道出血治疗设备市场：依最终用户分类

  • 门诊手术中心
  • 诊所
  • 医院
    • 私立医院
    • 公立医院

第九章美洲消化道出血治疗设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区消化道出血治疗设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲消化道出血治疗器械市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0286

The Gastrointestinal Bleeding Treatment Devices Market was valued at USD 534.43 million in 2023, expected to reach USD 559.43 million in 2024, and is projected to grow at a CAGR of 5.26%, to USD 765.43 million by 2030.

The market for gastrointestinal bleeding treatment devices is defined by a range of medical technologies aimed at diagnosing, managing, and treating bleeding in the gastrointestinal tract. This market's necessity is rooted in the prevalence of gastrointestinal conditions such as ulcers, varices, and cancers that can lead to critical bleeding incidents, necessitating efficient and effective intervention devices. Applications for these devices extend across endoscopic interventions, open surgeries, and minimally invasive procedures, catering to hospitals, specialized clinics, and ambulatory surgical centers. Key end-use domains include gastrointestinal surgery departments, emergency units, and specialized outpatient services. The market is currently driven by factors such as the growing incidence of gastrointestinal disorders, an aging global population, and advancements in minimally invasive surgical techniques. The integration of advanced imaging technologies and AI-driven diagnostics also spearhead industry growth, creating opportunities for companies to leverage technological partnerships and cross-industry collaborations. However, the market faces challenges including stringent regulatory requirements, high costs of advanced devices, and a need for skilled healthcare professionals. Market growth may also be hindered by limited healthcare infrastructure in developing regions. Innovators in this space should focus on developing cost-effective, portable solutions and enhancing device accuracy through AI and machine learning. Research areas with substantial potential include the development of biodegradable materials for temporary interventions and sensor technologies for real-time bleeding detection. Companies should consider engaging in robust R&D initiatives to address specific needs such as versatility in varied clinical settings and ease of device stratification for different gastrointestinal conditions. Understanding the nuanced dynamics of regional markets, particularly in Asia-Pacific and Latin America, where healthcare system expansion is ongoing, is essential for identifying untapped opportunities. Ultimately, fostering partnerships with healthcare providers and continuous adaptation to regulatory changes can significantly enhance positioning in this evolving market.

KEY MARKET STATISTICS
Base Year [2023] USD 534.43 million
Estimated Year [2024] USD 559.43 million
Forecast Year [2030] USD 765.43 million
CAGR (%) 5.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gastrointestinal Bleeding Treatment Devices Market

The Gastrointestinal Bleeding Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and favorable reimbursement policies for gastrointestinal bleeding treatments
    • Rising healthcare expenditure and improving healthcare infrastructure in emerging economies
    • Increasing adoption of minimally invasive procedures for treating gastrointestinal bleeding
    • Collaborations and partnerships between key players driving product development and market growth
  • Market Restraints
    • High costs associated with the development and deployment of advanced gastrointestinal bleeding treatment technologies
    • Limited awareness among general healthcare providers about advancements in gastrointestinal bleeding treatments
  • Market Opportunities
    • Integration of advanced diagnostic imaging technologies in gastrointestinal bleeding treatment devices to improve early detection and precision
    • Collaborations between gastrointestinal bleeding treatment device manufacturers and healthcare providers to enhance patient care and treatment outcomes
  • Market Challenges
    • Complex patient needs necessitate the development of highly specialized gastrointestinal bleeding treatment solutions

Porter's Five Forces: A Strategic Tool for Navigating the Gastrointestinal Bleeding Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gastrointestinal Bleeding Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gastrointestinal Bleeding Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gastrointestinal Bleeding Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gastrointestinal Bleeding Treatment Devices Market

A detailed market share analysis in the Gastrointestinal Bleeding Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gastrointestinal Bleeding Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gastrointestinal Bleeding Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gastrointestinal Bleeding Treatment Devices Market

A strategic analysis of the Gastrointestinal Bleeding Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastrointestinal Bleeding Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include 3M, Abbott Laboratories, Boston Scientific, CONMED Corporation, Cook Medical, Erbe Elektromedizin GmbH, Fujifilm Holdings Corporation, Hoya Corporation, Intuitive Surgical, Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic, Merit Medical Systems, Olympus, Pentax Medical, Smith & Nephew, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Gastrointestinal Bleeding Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Endoscopic Hemostatic Devices and Radiological Interventions. The Endoscopic Hemostatic Devices is further studied across Hemostatic Clips, Injection Devices, Spray Devices, and Thermal Devices. The Radiological Interventions is further studied across Embolization Agents and Sclerosants.
  • Based on Treatment Type, market is studied across Drug Therapy, Endoscopic Treatment, and Surgical Treatment. The Drug Therapy is further studied across Octreotide and Terlipressin. The Endoscopic Treatment is further studied across Injection Therapy, Mechanical Therapy, and Thermal Coagulation. The Surgical Treatment is further studied across Laparoscopic Surgery and Open Surgery.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and favorable reimbursement policies for gastrointestinal bleeding treatments
      • 5.1.1.2. Rising healthcare expenditure and improving healthcare infrastructure in emerging economies
      • 5.1.1.3. Increasing adoption of minimally invasive procedures for treating gastrointestinal bleeding
      • 5.1.1.4. Collaborations and partnerships between key players driving product development and market growth
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with the development and deployment of advanced gastrointestinal bleeding treatment technologies
      • 5.1.2.2. Limited awareness among general healthcare providers about advancements in gastrointestinal bleeding treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced diagnostic imaging technologies in gastrointestinal bleeding treatment devices to improve early detection and precision
      • 5.1.3.2. Collaborations between gastrointestinal bleeding treatment device manufacturers and healthcare providers to enhance patient care and treatment outcomes
    • 5.1.4. Challenges
      • 5.1.4.1. Complex patient needs necessitate the development of highly specialized gastrointestinal bleeding treatment solutions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gastrointestinal Bleeding Treatment Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Endoscopic Hemostatic Devices
    • 6.2.1. Hemostatic Clips
    • 6.2.2. Injection Devices
    • 6.2.3. Spray Devices
    • 6.2.4. Thermal Devices
  • 6.3. Radiological Interventions
    • 6.3.1. Embolization Agents
    • 6.3.2. Sclerosants

7. Gastrointestinal Bleeding Treatment Devices Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Drug Therapy
    • 7.2.1. Octreotide
    • 7.2.2. Terlipressin
  • 7.3. Endoscopic Treatment
    • 7.3.1. Injection Therapy
    • 7.3.2. Mechanical Therapy
    • 7.3.3. Thermal Coagulation
  • 7.4. Surgical Treatment
    • 7.4.1. Laparoscopic Surgery
    • 7.4.2. Open Surgery

8. Gastrointestinal Bleeding Treatment Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Hospitals
    • 8.4.1. Private Hospitals
    • 8.4.2. Public Hospitals

9. Americas Gastrointestinal Bleeding Treatment Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Gastrointestinal Bleeding Treatment Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Gastrointestinal Bleeding Treatment Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M
  • 2. Abbott Laboratories
  • 3. Boston Scientific
  • 4. CONMED Corporation
  • 5. Cook Medical
  • 6. Erbe Elektromedizin GmbH
  • 7. Fujifilm Holdings Corporation
  • 8. Hoya Corporation
  • 9. Intuitive Surgical
  • 10. Johnson & Johnson
  • 11. Karl Storz SE & Co. KG
  • 12. Medtronic
  • 13. Merit Medical Systems
  • 14. Olympus
  • 15. Pentax Medical
  • 16. Smith & Nephew
  • 17. Stryker Corporation
  • 18. Teleflex Incorporated
  • 19. Terumo Corporation
  • 20. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EMBOLIZATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SCLEROSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OCTREOTIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TERLIPRESSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MECHANICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 223. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 232. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 241. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 250. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 259. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 268. ISRAEL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUC